Professor Christof von Kalle has been director of the Department of Translational Oncology at the National Center for Tumor Diseases (NCT) and the German Cancer Research Center (DKFZ) since July 2005, chairing the NCT Board of Directors. As a physician scientist with a clinical background in hematology/oncology and more than 150 high-impact publications, Professor von Kalle is a leading scientist in stem-cell research, mutation analysis, and gene transfer. He is the president of the German Society for Gene Therapy (DG-GT) and board member of the European Society of Gene and Cell Therapy (ESGCT) as well as the European Association for Cancer Research (EACR). He is an elected member of the European Academy of Cancer Sciences (EACS) and spokesman of the Comprehensive Cancer Center (CCC) Network of German Cancer Aid. He coordinates overall activities at NCT with the primary goal of facilitating excellence in translational and clinical research.
